Arcutis Biotherapeutics (ARQT)
(Delayed Data from NSDQ)
$10.62 USD
-0.11 (-1.03%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $10.60 -0.02 (-0.19%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.49 | 0.00% |
Earnings Summary
For their last quarter, Arcutis Biotherapeutics (ARQT) reported earnings of -$0.32 per share, beating the Zacks Consensus Estimate of $-0.60 per share. This reflects a positive earnings surprise of 46.67%. Look out for ARQT's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.49 per share, reflecting a year-over-year increase of 57.76%.
Earnings History
Price & Consensus
Zacks News for ARQT
Pacira (PCRX) Rises on Proposed Exparel Reimbursement Plan
ARQT: What are Zacks experts saying now?
Zacks Private Portfolio Services